The selection and schedule of treatment should depend on patient preference and toxicity potential, according to Azka Ali, MD.

Researchers conducted an analysis of how NCCN guidelines for myeloma treatment are updated, offering suggestions for a more standardized process.

Patients are significantly more likely to experience treatment-related cardiac events with osimertinib than with other EGFR TKIs, data suggest.

For female patients aged at least 66 years, odds of prevalent CVD up with locally advanced and metastatic disease.

The prognosis of patients diagnosed with cancer after starting hemodialysis appears comparable to that of patients with cancer in the general population.

First-line pembrolizumab “has consistent antitumor activity and safety” in patients with advanced urothelial carcinoma who are potentially ineligible for platinum‐based chemotherapy, researchers found ...

Phase 3 data support pyrotinib plus trastuzumab and docetaxel “as a well-established and effective treatment strategy,” according to Binghe Xu, MD.

Researchers sought to determine the efficacy of a support program for patients with advanced cancer and their spouses who had minor children.

Modest absolute reduction in use observed, which increased during peak of shortage; no difference seen in mortality during shortage.

Researchers sought to determine if HRQoL measures differ with gilteritinib compared with placebo in patients with AML.

Researchers evaluated vitreoretinal lymphoma and concomitant central nervous system lymphoma testing modalities.

Researchers investigated the prevalence of psychiatric disorders and need for psycho-oncology support among patients with breast cancer.